Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current molecular medicine

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1566524011313040005PMID 22934847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor suppression by p53: fall of the triumvirate?

  2012cited by this paper
• Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism

  2012cited by this paper
• Fulfilling the metabolic requirements for cell proliferation.

  2012cited by this paper
• Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.

  2012cited by this paper
• Good neighbours in the tumour stroma reduce oxidative stress

  2012cited by this paper
• AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

  2012cited by this paper
• AMPK and GCN2-ATF4 signal the repression of mitochondria in colon cancer cells.

  2012cited by this paper
• Sirtuins mediate mammalian metabolic responses to nutrient availability

  2012cited by this paper
• Preparation and Characterization of l-[5-11C]-Glutamine for Metabolic Imaging of Tumors

  2012cited by this paper
• Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells.

  2012cited by this paper
• Interferon-α Regulates Glutaminase 1 Promoter through STAT1 Phosphorylation: Relevance to HIV-1 Associated Neurocognitive Disorders

  2012cited by this paper
• Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.

  2012cited by this paper
• MYC on the path to cancer.

  2012cited by this paper
• Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

  2012cited by this paper
• Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism

  2012cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• The Warburg effect in 2012

  2012cited by this paper
• An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression

  2012cited by this paper
• Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia

  2012cited by this paper
• The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response.

  2012cited by this paper
• Carbon source metabolism and its regulation in cancer cells.

  2012cited by this paper
• Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism

  2012cited by this paper
• miR-127-5p targets the 3'UTR of human β-F1-ATPase mRNA and inhibits its translation.

  2012cited by this paper
• E2F transcription factor-1 regulates oxidative metabolism

  2011cited by this paper
• Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells

  2011cited by this paper
• Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells.

  2011cited by this paper
• Kinetic Modeling of Hyperpolarized 13C Label Exchange between Pyruvate and Lactate in Tumor Cells*

  2011cited by this paper
• Oxidative phosphorylation as a target to arrest malignant neoplasias.

  2011cited by this paper
• Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.

  2011cited by this paper
• Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

  2011cited by this paper
• Reductive carboxylation supports growth in tumor cells with defective mitochondria

  2011cited by this paper
• Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells

  2011cited by this paper
• 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.

  2011cited by this paper
• Leucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Metabolic management of brain cancer.

  2011cited by this paper
• Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells

  2011cited by this paper
• A photoreactive small-molecule probe for 2-oxoglutarate oxygenases.

  2011cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• Anticancer antioxidant regulatory functions of phytochemicals.

  2011cited by this paper
• Pyruvate carboxylase is required for glutamine-independent growth of tumor cells

  2011cited by this paper
• L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of β-catenin-mutated human hepatocellular carcinoma cells.

  2011cited by this paper
• Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism.

  2011cited by this paper
• The CPT1C 5′UTR Contains a Repressing Upstream Open Reading Frame That Is Regulated by Cellular Energy Availability and AMPK

  2011cited by this paper
• Metabolic regulation by p53

  2011cited by this paper
• PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine

  2011cited by this paper
• Intertissue Flow of Glutathione (GSH) as a Tumor Growth-promoting Mechanism

  2011cited by this paper
• Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia

  2011cited by this paper
• Genome-Scale Metabolic Modeling Elucidates the Role of Proliferative Adaptation in Causing the Warburg Effect

  2011cited by this paper
• Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

  2011cited by this paper
• Comparative Metabolic Flux Profiling of Melanoma Cell Lines

  2011cited by this paper
• Therapeutic targeting of cancer cell metabolism

  2011cited by this paper
• Role of Glutamine in Cancer: Therapeutic and Imaging Implications

  2011cited by this paper
• A nuclear glutathione cycle within the cell cycle.

  2010cited by this paper
• Glutamine addiction: a new therapeutic target in cancer.

  2010cited by this paper
• Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: The relationship between mitochondrial damage, oxidative stress, and cell death.

  2010cited by this paper
• Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.

  2010cited by this paper
• Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells.

  2010cited by this paper
• Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

  2010cited by this paper
• Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation

  2010cited by this paper
• Q&A: Cancer: Clues from cell metabolism

  2010cited by this paper
• Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

  2010cited by this paper
• Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms.

  2010cited by this paper
• Metabolism strikes back: metabolic flux regulates cell signaling.

  2010cited by this paper
• Metastasis: cancer cell’s escape from oxidative stress

  2010cited by this paper
• Human duodenal proteome modulations by glutamine and antioxidants

  2010cited by this paper
• Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

  2010cited by this paper
• Alternative fuel—another role for p53 in the regulation of metabolism

  2010cited by this paper
• Apoptosis: Lack of oxygen aids cell survival

  2010cited by this paper
• Cancer metabolism: is glutamine sweeter than glucose?

  2010cited by this paper
• Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?

  2010cited by this paper
• The role of p53 in cell metabolism

  2010cited by this paper
• Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

  2010cited by this paper
• Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model

  2010cited by this paper
• Reactive oxygen species, cellular redox systems, and apoptosis.

  2010cited by this paper
• Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer

  2010cited by this paper
• Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

  2010cited by this paper
• Intermittent hypoxia augments acute hypoxic sensing via HIF-mediated ROS.

  2010cited by this paper
• BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function

  2010cited by this paper
• Imaging tumour cell metabolism using hyperpolarized 13C magnetic resonance spectroscopy.

  2010cited by this paper
• Stressin' Sestrins take an aging fight

  2010cited by this paper
• Control of mammalian gene expression by amino acids, especially glutamine

  2009cited by this paper
• Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia

  2009cited by this paper
• Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

  2009cited by this paper
• A novel glutaminase isoform in mammalian tissues.

  2009cited by this paper
• Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

  2009cited by this paper
• MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

  2009cited by this paper
• An amino acid shuffle activates mTORC1.

  2009cited by this paper
• Glutamine homeostasis and mitochondrial dynamics.

  2009cited by this paper
• c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses

  2009cited by this paper
• New insights into brain glutaminases: beyond their role on glutamatergic transmission.

  2009cited by this paper
• Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.

  2009cited by this paper
• Metabolic defects provide a spark for the epigenetic switch in cancer.

  2009cited by this paper
• Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy

  2009cited by this paper
• Transfection with liver‐type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells

  2009cited by this paper
• Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

  2009cited by this paper
• Redox-Based Escape Mechanism from Death: The Cancer Lesson

  2009cited by this paper
• SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes

  2008cited by this paper
• Inhibition of caspase-3 activity and activation by protein glutathionylation.

  2008cited by this paper

• Glutamine Synthetase: Spotlighting the Emerging Roles in Tumor Progression and Therapeutic Avenues.

  2026cites this paper
• Metabolic reprogramming and immunosenescence: a new sight for glioma therapy

  2026cites this paper
• Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity

  2025cites this paper
• Thermoresponsive antioxidant metal-free carbon nanodot hydrogel: An effective therapeutic approach for ocular surface disease

  2025cites this paper
• Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies

  2025cites this paper
• Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives.

  2025cites this paper
• Revolutionizing cancer treatment with Halomonas Aquamarina L-Glutaminase: insights from in vitro and computational studies

  2025cites this paper
• Slc7a7 licenses macrophage glutaminolysis for restorative functions in atherosclerosis

  2025cites this paper
• Dedifferentiation-Driven Oncogenic Stemness Promotes Tumor-Sustaining Adaptability in the Intestinal Epithelium

  2025cites this paper
• The metabolic shift of glutaminase 2 to glutaminase 1 promotes LGR5 + progenitor cell proliferation in liver cirrhosis

  2025cites this paper
• Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach

  2025cites this paper
• Prognostic and immune modulatory effects of ammonia-induced cell death in head and neck squamous cell carcinoma

  2025cites this paper
• Cuproptosis and cuproptosis-related cell death and genes: mechanistic links to spermatogenic cell death

  2025cites this paper
• HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell renal cell carcinoma

  2025cites this paper
• CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p

  2024cites this paper
• The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN

  2024cites this paper
• Cellular metabolism: A key player in cancer ferroptosis

  2024cites this paper
• Metabolism-related proteins as biomarkers for predicting prognosis in polycystic ovary syndrome

  2024cites this paper
• Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy

  2024cites this paper
• Analysis of nitrogen metabolism-related gene expression in hepatocellular carcinoma to establish relevant indicators for prediction of prognosis and guidance of immunotherapy.

  2024cites this paper
• Ammonia-induced stress response in liver disease progression and hepatic encephalopathy

  2024cites this paper
• Arsenic-induced disruption of circadian rhythms and glutamine anaplerosis in human urothelial carcinoma.

  2024cites this paper
• Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells

  2024cites this paper
• Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma.

  2024cites this paper
• The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.

  2024cites this paper
• Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance

  2024cites this paper
• HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell Renal Cell Carcinoma

  2024cites this paper
• Leukemia cancer cells and immune cells derived‐exosomes: Possible roles in leukemia progression and therapy

  2024cites this paper
• SLC1A5 regulates cell proliferation and self-renewal through β-catenin pathway mediated by redox signaling in arsenic-treated uroepithelial cells.

  2023cites this paper
• Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy

  2023cites this paper
• Glutaminase 1 isoform up-regulation associated with lipid metabolism disorder induced by methyl tertiary-butyl ether in male rats.

  2023cites this paper
• The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis

  2023cites this paper
• Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma

  2023cites this paper
• Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress

  2023cites this paper
• Emerging role of metabolic reprogramming in hyperoxia-associated neonatal diseases

  2023cites this paper
• System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma

  2023cites this paper
• Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway

  2023cites this paper
• Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence

  2023cites this paper
• Therapeutic Potential of Glutamine Pathway in Lung Cancer

  2022cites this paper
• Metabolic reprogramming and immunity in cancer

  2022cites this paper
• Heterogeneity of glutamine metabolism in acquired-EGFR-TKI-resistant lung cancer.

  2022cites this paper
• Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies

  2022cites this paper
• Overview of Cancer Metabolism and Signaling Transduction

  2022cites this paper
• Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease

  2022cites this paper
• Alterations in cellular metabolisms after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review

  2022cites this paper
• An Update on the Metabolic Landscape of Oncogenic Viruses

  2022cites this paper
• Design, synthesis, and pharmacological evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol analogs as novel glutaminase 1 inhibitors.

  2022cites this paper
• HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis

  2022cites this paper
• N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.

  2022cites this paper
• β-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene

  2022cites this paper
• HepaCAM-PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation

  2022cites this paper
• Regulation of Ferroptosis by Amino Acid Metabolism in Cancer

  2022cites this paper
• Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer

  2022cites this paper
• Metabolism of Amino Acids in Cancer

  2021influential citation
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper
• Identification and characterization of a novel glutaminase inhibitor

  2021cites this paper
• Design, Synthesis and in vitro Evaluation of 2-(Quinoline-8-sulfonamido)pentanedioic Acid Analogues as Antiangiogenic and Antitumor Agents on Multiple Myeloma

  2021cites this paper
• Therapeutic Targeting of Glutamine Metabolism in Colorectal Cancer

  2021cites this paper
• Regulatory role and mechanism of m6A RNA modification in human metabolic diseases

  2021cites this paper
• Antioxidant responses related to temozolomide resistance in glioblastoma.

  2021cites this paper
• Targeting GLS1 to cancer therapy through glutamine metabolism

  2021cites this paper
• Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.

  2021cites this paper
• Metabolic reprogramming in renal cancer: Events of a metabolic disease.

  2021cites this paper
• Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

  2021cites this paper
• DIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia

  2021cites this paper
• Role of LncRNAs in regulating cancer amino acid metabolism

  2021cites this paper
• The Role of MicroRNAs in Lung Cancer Metabolism

  2021cites this paper
• Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells

  2021influential citation
• Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma

  2021cites this paper
• Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas

  2020cites this paper
• Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders.

  2020cites this paper
• Identi cation the Roles of Ferroptosis-Related Gene Signatures in Patients with Esophageal Adenocarcinoma

  2020cites this paper
• Functional Role of p53 in the Regulation of Chemical-Induced Oxidative Stress

  2020cites this paper
• The Non-canonical Role of Metabolic Enzymes in Immune Cells and Its Impact on Diseases

  2020cites this paper
• Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.

  2020cites this paper
• The Glutaminase Inhibitor Compound 968 Exhibits Potent in vitro and in vivo Anti-tumor Effects in Endometrial Cancer.

  2020cites this paper
• Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies

  2020cites this paper
• Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas

  2020cites this paper
• The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer

  2020cites this paper
• Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p/GLS axis.

  2020cites this paper
• Glutaminases regulate glutathione and oxidative stress in cancer

  2020influential citation
• Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis

  2020cites this paper
• Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy

  2020cites this paper
• The role of glutaminase in cancer

  2020cites this paper
• Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

  2020cites this paper
• Dysregulation of glutaminase and glutamine synthetase in cancer.

  2019cites this paper
• Glutamine Addiction and Therapeutic Strategies in Lung Cancer

  2019cites this paper
• Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.

  2019cites this paper
• Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer

  2019cites this paper
• Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma

  2019cites this paper
• BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase

  2019cites this paper
• Functional characteristics of autophagy in pancreatic cancer induced by glutamate metabolism in pancreatic stellate cells

  2019cites this paper
• Effect of tert-butyl hydroperoxide in testicular metabolism

  2019cites this paper
• Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer

  2019cites this paper
• Investigation and calibration of non-essential amino acids using a custom built Raman spectroscopy system

  2019cites this paper
• Metabolic reprogramming of cancer by chemicals that target glutaminase isoenzymes.

  2019cites this paper
• The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension

  2019influential citation
• Design and synthesis of novel tellurodibenzoic acid compounds as kidney-type glutaminase (KGA) inhibitors.

  2019cites this paper
• Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response

  2018cites this paper
• Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism

  2018influential citation